I cannot believe it, I just posted this stuff, I hit the back button by accident and I return to this page and everything I had written has just disappeared. What a b**ch.
Ok here we go again
I have been looking into the processes that would be employed in producing HF from the methods discussed in this forum and I see a problem with it (I’m hoping someone will laugh at what I have to say, call me noob and we can all have a hearty laugh at my reservations). First let me go through the methodology and chemical processes that are involved, and then I’ll state what I find worrying.
Stage 1: Involves wounding skin sufficiently to induce active Stem Cells (SC) in the epidermis.
Satge 2: Apply Canonical Wnt producer (in our case Lithium Chloride, it may not have to be canonical as Wnt7a seems to be specifically mentioned). If I’m not mistaken Wnt is used to signal Tyronise Kinase (TK) activation, for the purpose of upregulating Beta Catenin (BC). The reason for doing so is that it increases expression of BC encouraging SC differentiation into a HF. So TK and BC are important factors in HF, or at least BC is.
Stage 3: Apply EGFR inhibitor in order to prevent wounded skin from producing normal numbers of skin cells for a specified time and in so doing encourage SC to differentiate into HF (I understand what’s being done here, but I don’t know what chemical process is taking place if anyone knows could you post it on the forum or where I might read about it).
Now these 3 stages look simple enough but we seem to be having some difficulty putting it together, namely, why we don’t have an EGFR that doesn’t negatively effect Wnt. I think I have the answer (although I’m still expecting someone to call me a noob, let me run this by you).
Firstly Wnt in whatever form is not the important factor, what is important is the fact that Wnt activates Tyronise Kinase receptors to signal production of Beta Catenin. So lets forget about Wnt for the time being and concentrate on TK and BC as these are the active ingredients (infact BC is the active ingredient). Right hold that thought, I’m now going to discuss EGFR inhibitors. These inhibitors (which are used as cancer drugs) work by covering the receptor that causes cell creation (and everything that goes with it) and cell apoptosis (cell death). The inhibitor that these drugs target is Tyronise Kinase. The EGFR inhibitor blocks the TK pathway preventing it from communicating with the rest of the cell, therefore it is not able to activate upregulation of Beta Catenin, meaning no differentiation from SC to HF can occur. I should also point out that erlotinib, gefitinib and milk thistle are all EGFR’s that inhibit Tyrosine Kinase, infact every EGFR inhibits TK. Could this be the reason why we haven’t yet found an EGFR that doesn’t deleteriously affect “Wntâ€.
Also if the above isn’t bullshit
I’d like to follow this through to what this should mean in practice:
1) People who used skin wounding and Wnt signalling (Lithium Chloride) should see either see meagre to moderate results. The reason is that whilst you are upregulating TK and BC you will produce more HF but also more epidermal skin cells.
2) People who used wounding and EGFR inhibitor would see no results at all. This is because EGFR would have blocked TK resulting in lower concentration of BC than normal.
3) People who used skin wounding and Wnt signaller and EGFR inhibitor should see no results. This is because EGFR would have blocked TK resulting in lower concentrations of BC than normal despite trying to upregulate it with Wnt.
Like I said I’m not sure if this is true, but I’d like to bounce the idea around this forum and see what comments you come up with, then I can go away and look into it some more.
Ok here we go again
I have been looking into the processes that would be employed in producing HF from the methods discussed in this forum and I see a problem with it (I’m hoping someone will laugh at what I have to say, call me noob and we can all have a hearty laugh at my reservations). First let me go through the methodology and chemical processes that are involved, and then I’ll state what I find worrying.
Stage 1: Involves wounding skin sufficiently to induce active Stem Cells (SC) in the epidermis.
Satge 2: Apply Canonical Wnt producer (in our case Lithium Chloride, it may not have to be canonical as Wnt7a seems to be specifically mentioned). If I’m not mistaken Wnt is used to signal Tyronise Kinase (TK) activation, for the purpose of upregulating Beta Catenin (BC). The reason for doing so is that it increases expression of BC encouraging SC differentiation into a HF. So TK and BC are important factors in HF, or at least BC is.
Stage 3: Apply EGFR inhibitor in order to prevent wounded skin from producing normal numbers of skin cells for a specified time and in so doing encourage SC to differentiate into HF (I understand what’s being done here, but I don’t know what chemical process is taking place if anyone knows could you post it on the forum or where I might read about it).
Now these 3 stages look simple enough but we seem to be having some difficulty putting it together, namely, why we don’t have an EGFR that doesn’t negatively effect Wnt. I think I have the answer (although I’m still expecting someone to call me a noob, let me run this by you).
Firstly Wnt in whatever form is not the important factor, what is important is the fact that Wnt activates Tyronise Kinase receptors to signal production of Beta Catenin. So lets forget about Wnt for the time being and concentrate on TK and BC as these are the active ingredients (infact BC is the active ingredient). Right hold that thought, I’m now going to discuss EGFR inhibitors. These inhibitors (which are used as cancer drugs) work by covering the receptor that causes cell creation (and everything that goes with it) and cell apoptosis (cell death). The inhibitor that these drugs target is Tyronise Kinase. The EGFR inhibitor blocks the TK pathway preventing it from communicating with the rest of the cell, therefore it is not able to activate upregulation of Beta Catenin, meaning no differentiation from SC to HF can occur. I should also point out that erlotinib, gefitinib and milk thistle are all EGFR’s that inhibit Tyrosine Kinase, infact every EGFR inhibits TK. Could this be the reason why we haven’t yet found an EGFR that doesn’t deleteriously affect “Wntâ€.
Also if the above isn’t bullshit
I’d like to follow this through to what this should mean in practice:
1) People who used skin wounding and Wnt signalling (Lithium Chloride) should see either see meagre to moderate results. The reason is that whilst you are upregulating TK and BC you will produce more HF but also more epidermal skin cells.
2) People who used wounding and EGFR inhibitor would see no results at all. This is because EGFR would have blocked TK resulting in lower concentration of BC than normal.
3) People who used skin wounding and Wnt signaller and EGFR inhibitor should see no results. This is because EGFR would have blocked TK resulting in lower concentrations of BC than normal despite trying to upregulate it with Wnt.
Like I said I’m not sure if this is true, but I’d like to bounce the idea around this forum and see what comments you come up with, then I can go away and look into it some more.